gastrointestinal tumors
Conditions
Interventions
Observation group:none
Sponsors
Nantong Tumor Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Patients with gastrointestinal tumors confirmed by pathology or cytology; 2.Age >=18 years, no gender restriction; 3.ECOG performance status 0–2; 4.Deemed eligible by the investigator to receive QL1706-based combination therapy; 5.Patients voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1.Confirmed pregnancy or breastfeeding; 2.Other conditions that, in the investigator’s judgment, make the patient unsuitable for inclusion in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| safety(Including the occurrence of all adverse events during the treatment period, especially those related to the immune system.); | — |
Secondary
| Measure | Time frame |
|---|---|
| Progression-free survival;Disease control rate;Objective response rate;Overall survival; | — |
Countries
China
Contacts
Public ContactLei Yang
Nantong Tumor Hospital
Outcome results
None listed